Gut Microbiota and Oral Contraceptive Use in Women with Polycystic Ovary Syndrome: A Systematic Review
Nutrients · 2024
DOI: 10.3390/nu16193382 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, 2024. Verfasst von Jakub Wydra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland. Hauptthemen laut MEDLINE: Contraceptives, Oral, Gastrointestinal Microbiome, Polycystic Ovary Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Centre of Postgraduate Medical Education, Warsaw, Poland.
Abstract (Originalsprache)
Background
Polycystic ovary syndrome (PCOS) is one of the most prevalent endocrine syndromes affecting women at reproductive age. With increasing knowledge of the role of the microbiota in the pathogenesis of PCOS, new management strategies began to emerge. However, data on the impact of established treatment regimens, such as metformin and oral contraceptive agents, on the gut microbiota composition are scarce. This study aimed to evaluate the specificity of the gut microbiota in women with PCOS before and after treatment with oral contraceptives.
Methods
We have systematically searched the following databases: PubMed/MEDLINE, Scopus, Web of Science and Google Scholar. The last search was performed on 13 May 2024. We included only full-text original research articles written in English. The risk of bias was assessed using a modified version of the Newcastle–Ottawa Scale.
Results
The above described search strategy retrieved 46 articles. Additionally, 136 articles were identified and screened through Google Scholar. After removing duplicates, we screened the titles and abstracts, resulting in three eligible articles constituting the final pool. They were published between 2020 and 2022 and are based on three ethnically distinct study populations: Turkish, Spanish and American. The studies included a total of 37 women diagnosed with PCOS and using OCs.
Conclusions
OC treatment does not seem to affect the gut microbiota in a significant way in patients with PCOS in short observation. Well-designed randomized controlled studies with adequate, unified sample size are lacking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland.
- Second Department of Obstetrics and Gynecology, Centre of Postgraduate Medical Education, 00-189 Warsaw, Poland.
- Warsaw Institute of Women's Health, 00-189 Warsaw, Poland.
- Department of Obstetrics, Perinatology and Neonatology, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland.
- Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, 02-781 Warsaw, Poland.
ORCID-Profile: Jakub Wydra, Michał Ciebiera
Förderung
- Centre of Postgraduate Medical Education, Warsaw, Poland
Zitieren
APA
Wydra, J., Szlendak-Sauer, K., Zgliczyńska, M., Żeber-Lubecka, N., & Ciebiera, M. (2024). Gut Microbiota and Oral Contraceptive Use in Women with Polycystic Ovary Syndrome: A Systematic Review. Nutrients. https://doi.org/10.3390/nu16193382
Vancouver
Wydra J, Szlendak-Sauer K, Zgliczyńska M, Żeber-Lubecka N, Ciebiera M. Gut Microbiota and Oral Contraceptive Use in Women with Polycystic Ovary Syndrome: A Systematic Review. Nutrients. 2024. doi:10.3390/nu16193382
BibTeX
@article{Wydra2024,
author = {Wydra, Jakub and Szlendak-Sauer, Katarzyna and Zgliczyńska, Magdalena and Żeber-Lubecka, Natalia and Ciebiera, Michał},
title = {Gut Microbiota and Oral Contraceptive Use in Women with Polycystic Ovary Syndrome: A Systematic Review},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16193382}
}
EUVIMED